PCN36 COST ANALYSIS, SAFETY, AND EFFICACY OF PEMETREXED/CISPLATIN COMPARED WITH BEVACIZUMAB/GEMCITABINE/CISPLATIN IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED NON-SQUAMOUS NSCLC IN RUSSIA
Abstract
Authors
P. Davey N. Rajan Y. Kanivets H. Barraclough M. Orlando A.J. Brnabic B. Han